BioMarin Pharmaceutical
BMRN
#1907
Rank
C$14.32 B
Marketcap
C$74.54
Share price
-0.78%
Change (1 day)
-19.64%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$2.17 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total liabilities are C$2.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioMarin Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$1.90 B-23.81%
2023-12-31C$2.50 B4.26%
2022-12-31C$2.40 B8.48%
2021-12-31C$2.21 B-0.22%
2020-12-31C$2.22 B8.49%
2019-12-31C$2.04 B3.01%
2018-12-31C$1.98 B-13.34%
2017-12-31C$2.29 B35.75%
2016-12-31C$1.68 B-8.31%
2015-12-31C$1.84 B67.61%
2014-12-31C$1.09 B14.38%
2013-12-31C$0.96 B74.94%
2012-12-31C$0.54 B1.41%
2011-12-31C$0.54 B-0.61%
2010-12-31C$0.54 B-12.92%
2009-12-31C$0.62 B-18.28%
2008-12-31C$0.76 B22.36%
2007-12-31C$0.62 B55.57%
2006-12-31C$0.40 B26.72%
2005-12-31C$0.31 B-12.14%
2004-12-31C$0.36 B101.21%
2003-12-31C$0.17 B842.13%
2002-12-31C$19.06 M-2.39%
2001-12-31C$19.53 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ultragenyx Pharmaceutical
RARE
C$1.63 B-24.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$0.11 B-94.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$1.13 B-47.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$92.17 B 4,137.50%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
C$0.89 B-59.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$0.18 B-91.57%๐Ÿ‡บ๐Ÿ‡ธ USA